1. Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients.
- Author
-
Cunha LRD, Vieira DA, Giampietro YG, Gomes AD, Lopes de Faria CL Jr, Freire de Melo F, Teixeira R, Teixeira de Carvalho A, Oliveira LM, Filho OAM, Rocha GA, Maria de Magalhães Queiroz D, Neves FS, and Silva LD
- Subjects
- Adult, Age Factors, Alcohol Drinking psychology, Biomarkers blood, Case-Control Studies, Chi-Square Distribution, Depressive Disorder, Major blood, Female, Haplotypes, Hepatitis C, Chronic blood, Humans, Interferon-gamma blood, Interleukin-10 blood, Interleukin-2 blood, Interleukin-6 blood, Male, Middle Aged, Odds Ratio, Prospective Studies, Tumor Necrosis Factor-alpha blood, Young Adult, Depressive Disorder, Major genetics, Hepatitis C, Chronic genetics, Hepatitis C, Chronic psychology, Interleukin-10 genetics, Polymorphism, Single Nucleotide, Promoter Regions, Genetic
- Abstract
Aims: To investigate the association of IL10 SNPs in chronic hepatitis C (CHC) patients with and without the first major depressive episode (MDE), as well as their association with plasma levels of target cytokines., Methods: A hundred and thirty two CHC patients (32 with and 100 without first MDE) and 98 controls were prospectively enrolled in this cross-sectional study. MDE was diagnosed by a psychiatrist, using the Mini International Neuropsychiatric Interview Plus 5.0. IL10 polymorphisms (-1082 G/A, -819C/T and -592C/A IL10 SNPs) were evaluated by Taqman SNP genotyping assay. Plasma concentrations of IL-2, IL-6, IL-10, IFN-γ and TNF-α were determined using the Human Th1/Th2 Cytometric Bead Array kit. The associations were investigated by logistic models., Results: The frequencies of the studied IL10 SNPs did not differ between the CHC patients and controls. The first MDE was positive and independently associated with the IL10-1082*A, IL10-819*T and IL10-592*A (ATA) low producer haplotype (OR = 1.50; 95% CI = 1.11-2.04; P = 0.009) and current alcohol misuse (OR = 4.29; 95% CI = 1.22-15.05; P = 0.02), and inversely associated with increasing age (OR = 0.94; 95% CI = 0.91-0.98; P = 0.006). In addition, plasma level of TNF-α was significantly higher in the carriers than in the non-carriers of the IL10 ATA haplotype in patients with the first MDE. The IL-10 and IL-2 plasma levels were significantly higher in the carriers than in non-carriers of the IL10 GCC high producer haplotype, demonstrating the functionality of the studied IL10 polymorphisms., Conclusions: This is the first study to demonstrate that the IL10 low producer ATA haplotype is associated with the first MDE in patients with CHC., (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF